Case reportPurpuric herpes zoster in patients in therapy with clopidogrel

Add time:09/06/2019    Source:sciencedirect.com

Clopidogrel is an adenosine diphosphate receptor antagonist used for the prevention of vascular events in patients with atherothrombotic diseases manifested by recent myocardial infarction, ischemic stroke or peripheral arterial disease. Diarrhoea, rash and pruritus are rather common side effects of clopidogrel. Other side effects include epistaxis, nausea, abdominal pain, vomiting, gastritis, gastric and duodenal ulcer. Thrombocytopenia is the most common laboratory abnormality. Leucopenia and neutropenia are rare. We report three cases of purpuric herpes zoster in patients in therapy with clopidogrel. To our knowledge, only one case of haemorrhagic herpes zoster has been published in a patient in therapy with this drug.

We also recommend Trading Suppliers and Manufacturers of purpuric acid (cas 121-08-4). Pls Click Website Link as below: cas 121-08-4 suppliers

Prev:Case ReportPigmented Purpuric Dermatosis in Adults Treated with Herbal Medicine: Report of Five Cases
Next:Case reportParvovirus B19-associated purpuric–petechial eruption)